6GT5 image
Entry Detail
PDB ID:
6GT5
Keywords:
Title:
METTL16 MTase domain (crystal form 2)
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2018-06-15
Release Date:
2018-09-19
Method Details:
Experimental Method:
Resolution:
2.45 Å
R-Value Free:
0.24
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase
Chain IDs:A, B
Chain Length:291
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.
Mol. Cell 71 986 1000.e11 (2018)
PMID: 30197299 DOI: 10.1016/j.molcel.2018.08.004

Abstact

Internal modification of RNAs with N6-methyladenosine (m6A) is a highly conserved means of gene expression control. While the METTL3/METTL14 heterodimer adds this mark on thousands of transcripts in a single-stranded context, the substrate requirements and physiological roles of the second m6A writer METTL16 remain unknown. Here we describe the crystal structure of human METTL16 to reveal a methyltransferase domain furnished with an extra N-terminal module, which together form a deep-cut groove that is essential for RNA binding. When presented with a random pool of RNAs, METTL16 selects for methylation-structured RNAs where the critical adenosine is present in a bulge. Mouse 16-cell embryos lacking Mettl16 display reduced mRNA levels of its methylation target, the SAM synthetase Mat2a. The consequence is massive transcriptome dysregulation in ∼64-cell blastocysts that are unfit for further development. This highlights the role of an m6A RNA methyltransferase in facilitating early development via regulation of SAM availability.

Legend

Protein

Chemical

Disease

Primary Citation of related structures